Purpose Sexual well-being has been identified as an unmet supportive care need among
many individuals with genitourinary (GU) cancers. Little is known about the experiences of …

Biofluid-based biomarker tests hold great promise for precision medicine in prostate cancer
(PCa) clinical practice. Extracellular vesicles (EV) are established as intercellular …

Purpose To describe the development and first outcomes of the Utrecht Prostate Cohort
(UPC): the first 'trials within cohorts'(TwiCs) platform for prostate cancer (PCa). Methods All …

Purpose: Active surveillance is widely used to manage low-risk prostate cancer, but
population-level long-term outcomes are limited. Our objective was to determine long-term …

Prostate cancer (PCa) patients and survivors are at high risk of mental health illness. Here,
we examined the contribution of treatment regret, mental and physical health indicators to …

Introduction Androgen deprivation therapy (ADT) is commonly used to treat men with locally
advanced or metastatic prostate cancer. Men receiving ADT experience numerous side …

Abstract Background Prostate cancer (PCa) is the most diagnosed cancer in Australian men,
and the number of survivors is growing with advances in diagnosis and treatment. Work …

Simple Summary Pelvic radiotherapy is used to treat a range of cancers. Radiotherapy can
damage surrounding, non-cancerous tissue and organs, causing long-term problems …

Objective: Radical prostatectomy (RP) is a frequent treatment for men suffering from
localized prostate cancer (PCa). Whilst offering a high chance for cure, it does not come …

Background The effects of radiotherapy (RT) patients' health-related quality of life (HRQoL)
are usually compared to those of other treatment modalities instead of HRQoL of the general …